2 completed, 1 active not recruiting, 1 not yet recruiting. 1 Not applicable, 1 Phase 3, 1 Phase 4.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Completed 1 |
| Phase 3 | 1 | Not yet recruiting 1 |
| Phase 4 | 1 | Completed 1 |
Follow Preservation, Biological: new trials by email Literature Review of Preservation, Biological trials Research Report on Preservation, Biological
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Clinical Trial for the Evaluation of Safety and Efficacy of Drop 0.4% Multidose mosturizing solution DROP 0.4%, Multidose mosturizing solution Avizor Eye Drops 0.2% Preserved - Eye Dryness | Phase 3 | Not yet recruiting | Avizor SA | 79 | 2025-07-01 | 2025-07-09 |
| Microbiota in Urine and Urothelium Can be a Factor for Induction of Urinary Bladder Cancer. The Study Will Examine Urine and Bladder Cancer Tissues From Male Patients and Urine of Controls Using Whole Genomic Sequencing Techniques and 16S rRNA. The Aim is to Elucidate Role of Microbiota in Bladder Urine samples and tissue samples: Samples will be collected in clean leak-proof containers without disinfectant or detergent residue and with tight-fitting leak-proof lids and preserved in a refrigera - Urinary Bladder Neoplasms, Microtia | Active not recruiting | Theodor Bilharz Research Institute | 38 | 2023-10-12 | 2024-03-01 | |
| Preservation of Endopelvic Fascia: Effects on Postoperative Incontinence and Impotence. Randomized Clinical Trial. Preservation (endopelvic fascia), Opening (endopelvic fascia) - Prostatic Neoplasms, Urinary Incontinence | Not applicable | Completed | Tampere University Hospital | 158 | 2015-08-01 | 2019-09-18 |
| Performance and Acceptance of Optive Versus Hylocomod Eyedrops in Patients With Dry Eye Symptoms A sterile solution containing sodium carboxymethylcellulose and glycerin, preserved with PURITE®, Sodium hyaluronate - Dry Eye Syndromes | Phase 4 | Completed | Allergan | 50 | 2007-08-01 | 2013-11-19 |
Dry Eye Syndromes (2) · Congenital Microtia (1) · Erectile Dysfunction (1) · Prostatic Neoplasms (1) · Urinary Bladder Neoplasms (1) · Urinary Incontinence (1) · Xerophthalmia (1)
Allergan (1) · Avizor SA (1) · Tampere University Hospital (1) · Theodor Bilharz Research Institute (1)
Egypt (1) · Finland (1) · United Kingdom (1)